Zheng, Xiao-Dong https://orcid.org/0000-0002-5495-3216
Li, Shi-Cong
Lu, Chao
Zhang, Wei-Ming
Hou, Jian-Bin
Shi, Ke-Feng
Zhang, Peng
Article History
Received: 15 April 2021
Accepted: 6 March 2022
First Online: 15 March 2022
Declarations
:
: The present study was a part of Phase III clinical trial (ClinicalTrials.gov Identifier: NCT02448979) sponsored by the Institutional Review Board of Cancer Hospital, Chinese Academy of Medical Science and received ethics board approval (NCC2014 ZC-01).
: Not applicable.
: The authors declare that they have no competing interests.